drugset / Trial / NCT05857631

Postoperative Hypofractionated Radiation in Cervical and Endometrial Tumours: Phase II Study

NCT05857631

Recruiting 90 enrolled Tata Memorial Centre
NaSingle-groupOpen-labelTreatment

Summary

The primary aim of the trial is to investigate the late effects of hypofractionated external radiation (39 Gy in 13 fractions) in patients requiring post-operative radiation for early-stage cervical and endometrial cancers.

Timeline

Start
2023-05-29
Primary completion
2029-05-25
Completion
2029-05-25

Drugs

EvaluationDrugModalityDoseRoute
Background Cisplatin Other / unclassified 40 mg/m2 Intravenous